Prognostic impact of extent of vascular invasion in low-grade encapsulated follicular cell-derived thyroid carcinomas: a clinicopathologic study of 276 cases.

[1]  J. Shah,et al.  Thyroid carcinoma, version 2.2014. , 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

[2]  N. Socci,et al.  Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. , 2013, The Journal of clinical endocrinology and metabolism.

[3]  S. Roman,et al.  Hurthle cell carcinoma , 2013, Cancer.

[4]  S. Asa,et al.  Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation , 2011, Modern Pathology.

[5]  Stephanie L. Lee,et al.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.

[6]  J. Shah,et al.  Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). , 2009, Thyroid : official journal of the American Thyroid Association.

[7]  H. Kuwano,et al.  Nuclear β-Catenin Expression at the Invasive Front and in the Vessels Predicts Liver Metastasis in Colorectal Carcinoma , 2008 .

[8]  Louise Davies,et al.  Increasing incidence of thyroid cancer in the United States, 1973-2002. , 2006, JAMA.

[9]  J. Shah,et al.  Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland , 2006, Cancer.

[10]  Q. Duh,et al.  Follicular thyroid carcinoma: Histology and prognosis , 2004, Cancer.

[11]  S. Pilotti,et al.  Extensive vascular invasion is a marker of risk of relapse in encapsulated non‐Hürthle cell follicular carcinoma of the thyroid gland: a clinicopathological study of 18 consecutive cases from a single institution with a 11‐year median follow‐up , 2004, Histopathology.

[12]  N. Ordóñez,et al.  Prognostic factors in patients with Hürthle cell neoplasms of the thyroid , 2003, Cancer.

[13]  N. Goldstein,et al.  Metastatic Minimally Invasive (Encapsulated) Follicular and Hurthle Cell Thyroid Carcinoma: A Study of 34 Patients , 2000, Modern Pathology.

[14]  L. Woolner,et al.  Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. , 1986, Mayo Clinic proceedings.

[15]  H. Hundeshagen,et al.  Risk Factors in Follicular Thyroid Carcinomas: A Retrospective Follow-up Study Covering a 14-Year Period with Emphasis on Morphological Findings , 1986, The American journal of surgical pathology.

[16]  T. Thomas.  Malignant Epithelial Tumors of the Thyroid , 1925 .

[17]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[18]  M. Hirokawa,et al.  Prognostic factors of minimally invasive follicular thyroid carcinoma: extensive vascular invasion significantly affects patient prognosis. , 2013, Endocrine journal.

[19]  H. Kuwano,et al.  Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. , 2008, Anticancer research.

[20]  R. DeLellis.  Pathology and genetics of tumours of endocrine organs , 2004 .

[21]  J. Rosai,et al.  Tumors of the thyroid gland , 1992 .

[22]  E. Bergstralh,et al.  Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. , 1991, Mayo Clinic proceedings.

[23]  W. Lehman.  Tumors of the thyroid gland. , 1950, Northwest medicine.